nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivaroxaban—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0567	0.0775	CbGbCtD
Rivaroxaban—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0513	0.0701	CbGbCtD
Rivaroxaban—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0513	0.0701	CbGbCtD
Rivaroxaban—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0443	0.0605	CbGbCtD
Rivaroxaban—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.043	0.0587	CbGbCtD
Rivaroxaban—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.0389	0.0531	CbGbCtD
Rivaroxaban—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.0389	0.0531	CbGbCtD
Rivaroxaban—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0369	0.0504	CbGbCtD
Rivaroxaban—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0334	0.0456	CbGbCtD
Rivaroxaban—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0288	0.0394	CbGbCtD
Rivaroxaban—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.028	0.0382	CbGbCtD
Rivaroxaban—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0253	0.0346	CbGbCtD
Rivaroxaban—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0253	0.0346	CbGbCtD
Rivaroxaban—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0243	0.0331	CbGbCtD
Rivaroxaban—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0235	0.0321	CbGbCtD
Rivaroxaban—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0221	0.0302	CbGbCtD
Rivaroxaban—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0221	0.0302	CbGbCtD
Rivaroxaban—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.02	0.0273	CbGbCtD
Rivaroxaban—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.02	0.0273	CbGbCtD
Rivaroxaban—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.0188	0.0256	CbGbCtD
Rivaroxaban—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0173	0.0236	CbGbCtD
Rivaroxaban—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0168	0.0229	CbGbCtD
Rivaroxaban—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0152	0.0207	CbGbCtD
Rivaroxaban—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0152	0.0207	CbGbCtD
Rivaroxaban—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0145	0.0199	CbGbCtD
Rivaroxaban—F10—blood plasma—acquired immunodeficiency syndrome	0.00572	0.163	CbGeAlD
Rivaroxaban—CYP2J2—skin of body—acquired immunodeficiency syndrome	0.00225	0.0644	CbGeAlD
Rivaroxaban—F10—blood—acquired immunodeficiency syndrome	0.00209	0.0599	CbGeAlD
Rivaroxaban—F10—vagina—acquired immunodeficiency syndrome	0.00194	0.0555	CbGeAlD
Rivaroxaban—F10—lung—acquired immunodeficiency syndrome	0.00184	0.0525	CbGeAlD
Rivaroxaban—CYP2J2—spinal cord—acquired immunodeficiency syndrome	0.00165	0.0473	CbGeAlD
Rivaroxaban—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.00165	0.0472	CbGeAlD
Rivaroxaban—CYP2J2—vagina—acquired immunodeficiency syndrome	0.00159	0.0455	CbGeAlD
Rivaroxaban—CYP2J2—lung—acquired immunodeficiency syndrome	0.0015	0.043	CbGeAlD
Rivaroxaban—CYP2J2—nervous system—acquired immunodeficiency syndrome	0.00139	0.0398	CbGeAlD
Rivaroxaban—CYP2J2—central nervous system—acquired immunodeficiency syndrome	0.00134	0.0384	CbGeAlD
Rivaroxaban—F10—lymph node—acquired immunodeficiency syndrome	0.00126	0.0359	CbGeAlD
Rivaroxaban—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00124	0.0354	CbGeAlD
Rivaroxaban—CYP2J2—brain—acquired immunodeficiency syndrome	0.00107	0.0305	CbGeAlD
Rivaroxaban—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000876	0.025	CbGeAlD
Rivaroxaban—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000634	0.0181	CbGeAlD
Rivaroxaban—CYP3A5—blood—acquired immunodeficiency syndrome	0.000604	0.0173	CbGeAlD
Rivaroxaban—CYP3A5—vagina—acquired immunodeficiency syndrome	0.00056	0.016	CbGeAlD
Rivaroxaban—CYP3A5—lung—acquired immunodeficiency syndrome	0.00053	0.0151	CbGeAlD
Rivaroxaban—ABCB1—retina—acquired immunodeficiency syndrome	0.00048	0.0137	CbGeAlD
Rivaroxaban—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000476	0.0136	CbGeAlD
Rivaroxaban—CYP3A4—blood—acquired immunodeficiency syndrome	0.000453	0.013	CbGeAlD
Rivaroxaban—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000368	0.0105	CbGeAlD
Rivaroxaban—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000354	0.0101	CbGeAlD
Rivaroxaban—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000341	0.00975	CbGeAlD
Rivaroxaban—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000337	0.00963	CbGeAlD
Rivaroxaban—ABCB1—blood—acquired immunodeficiency syndrome	0.000321	0.00918	CbGeAlD
Rivaroxaban—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000311	0.00888	CbGeAlD
Rivaroxaban—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000309	0.00884	CbGeAlD
Rivaroxaban—ABCB1—vagina—acquired immunodeficiency syndrome	0.000297	0.00851	CbGeAlD
Rivaroxaban—ABCB1—lung—acquired immunodeficiency syndrome	0.000281	0.00804	CbGeAlD
Rivaroxaban—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000261	0.00745	CbGeAlD
Rivaroxaban—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.000257	0.0011	CcSEcCtD
Rivaroxaban—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000257	0.0011	CcSEcCtD
Rivaroxaban—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000256	0.0011	CcSEcCtD
Rivaroxaban—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.000254	0.00109	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.000253	0.00109	CcSEcCtD
Rivaroxaban—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.000253	0.00108	CcSEcCtD
Rivaroxaban—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.000252	0.00108	CcSEcCtD
Rivaroxaban—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000252	0.00108	CcSEcCtD
Rivaroxaban—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000252	0.00108	CcSEcCtD
Rivaroxaban—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.000251	0.00108	CcSEcCtD
Rivaroxaban—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000251	0.00717	CbGeAlD
Rivaroxaban—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000248	0.00107	CcSEcCtD
Rivaroxaban—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000248	0.00106	CcSEcCtD
Rivaroxaban—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000247	0.00106	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000247	0.00106	CcSEcCtD
Rivaroxaban—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000247	0.00106	CcSEcCtD
Rivaroxaban—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000247	0.00106	CcSEcCtD
Rivaroxaban—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000246	0.00106	CcSEcCtD
Rivaroxaban—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000246	0.00105	CcSEcCtD
Rivaroxaban—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000246	0.00105	CcSEcCtD
Rivaroxaban—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000245	0.00105	CcSEcCtD
Rivaroxaban—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000245	0.00105	CcSEcCtD
Rivaroxaban—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000245	0.00105	CcSEcCtD
Rivaroxaban—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000245	0.00105	CcSEcCtD
Rivaroxaban—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000245	0.00105	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000244	0.00105	CcSEcCtD
Rivaroxaban—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000244	0.00105	CcSEcCtD
Rivaroxaban—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000243	0.00104	CcSEcCtD
Rivaroxaban—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000243	0.00104	CcSEcCtD
Rivaroxaban—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000242	0.00104	CcSEcCtD
Rivaroxaban—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000242	0.00104	CcSEcCtD
Rivaroxaban—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000242	0.00104	CcSEcCtD
Rivaroxaban—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000241	0.00103	CcSEcCtD
Rivaroxaban—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000241	0.00103	CcSEcCtD
Rivaroxaban—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.00024	0.00103	CcSEcCtD
Rivaroxaban—Rash—Didanosine—acquired immunodeficiency syndrome	0.000239	0.00103	CcSEcCtD
Rivaroxaban—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000239	0.00103	CcSEcCtD
Rivaroxaban—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000239	0.00103	CcSEcCtD
Rivaroxaban—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000239	0.00103	CcSEcCtD
Rivaroxaban—Headache—Didanosine—acquired immunodeficiency syndrome	0.000238	0.00102	CcSEcCtD
Rivaroxaban—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000238	0.00102	CcSEcCtD
Rivaroxaban—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000237	0.00102	CcSEcCtD
Rivaroxaban—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000237	0.00102	CcSEcCtD
Rivaroxaban—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000237	0.00102	CcSEcCtD
Rivaroxaban—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000237	0.00101	CcSEcCtD
Rivaroxaban—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000236	0.00101	CcSEcCtD
Rivaroxaban—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000236	0.00101	CcSEcCtD
Rivaroxaban—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000235	0.00101	CcSEcCtD
Rivaroxaban—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000235	0.00101	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000234	0.00101	CcSEcCtD
Rivaroxaban—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000234	0.001	CcSEcCtD
Rivaroxaban—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000234	0.001	CcSEcCtD
Rivaroxaban—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000234	0.001	CcSEcCtD
Rivaroxaban—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000233	0.001	CcSEcCtD
Rivaroxaban—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000233	0.001	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000233	0.000998	CcSEcCtD
Rivaroxaban—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000232	0.000997	CcSEcCtD
Rivaroxaban—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000232	0.000994	CcSEcCtD
Rivaroxaban—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000231	0.000991	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000231	0.00099	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00023	0.000987	CcSEcCtD
Rivaroxaban—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00023	0.000986	CcSEcCtD
Rivaroxaban—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.00023	0.000986	CcSEcCtD
Rivaroxaban—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00023	0.000985	CcSEcCtD
Rivaroxaban—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000229	0.000982	CcSEcCtD
Rivaroxaban—Pain—Indinavir—acquired immunodeficiency syndrome	0.000228	0.000978	CcSEcCtD
Rivaroxaban—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000228	0.000978	CcSEcCtD
Rivaroxaban—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000228	0.000976	CcSEcCtD
Rivaroxaban—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000227	0.000975	CcSEcCtD
Rivaroxaban—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000227	0.000972	CcSEcCtD
Rivaroxaban—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000226	0.000971	CcSEcCtD
Rivaroxaban—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000226	0.00097	CcSEcCtD
Rivaroxaban—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000226	0.000968	CcSEcCtD
Rivaroxaban—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000226	0.000968	CcSEcCtD
Rivaroxaban—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000225	0.000966	CcSEcCtD
Rivaroxaban—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000225	0.000964	CcSEcCtD
Rivaroxaban—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000225	0.000963	CcSEcCtD
Rivaroxaban—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000224	0.000959	CcSEcCtD
Rivaroxaban—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000223	0.000956	CcSEcCtD
Rivaroxaban—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000222	0.000953	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000222	0.000953	CcSEcCtD
Rivaroxaban—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000222	0.000951	CcSEcCtD
Rivaroxaban—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000221	0.000948	CcSEcCtD
Rivaroxaban—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.00022	0.000945	CcSEcCtD
Rivaroxaban—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.00022	0.000942	CcSEcCtD
Rivaroxaban—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000219	0.00094	CcSEcCtD
Rivaroxaban—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000219	0.000938	CcSEcCtD
Rivaroxaban—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000219	0.000938	CcSEcCtD
Rivaroxaban—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000219	0.000937	CcSEcCtD
Rivaroxaban—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000218	0.000935	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000218	0.000935	CcSEcCtD
Rivaroxaban—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000217	0.000933	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000217	0.000932	CcSEcCtD
Rivaroxaban—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000217	0.000931	CcSEcCtD
Rivaroxaban—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000217	0.000931	CcSEcCtD
Rivaroxaban—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000216	0.000928	CcSEcCtD
Rivaroxaban—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000215	0.000924	CcSEcCtD
Rivaroxaban—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000215	0.000924	CcSEcCtD
Rivaroxaban—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000215	0.000923	CcSEcCtD
Rivaroxaban—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000215	0.000923	CcSEcCtD
Rivaroxaban—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000215	0.000921	CcSEcCtD
Rivaroxaban—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000215	0.000921	CcSEcCtD
Rivaroxaban—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000214	0.00092	CcSEcCtD
Rivaroxaban—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000214	0.000918	CcSEcCtD
Rivaroxaban—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000213	0.000915	CcSEcCtD
Rivaroxaban—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000213	0.000914	CcSEcCtD
Rivaroxaban—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000212	0.00091	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000212	0.000909	CcSEcCtD
Rivaroxaban—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000212	0.000908	CcSEcCtD
Rivaroxaban—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000211	0.000905	CcSEcCtD
Rivaroxaban—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000211	0.000904	CcSEcCtD
Rivaroxaban—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000211	0.000904	CcSEcCtD
Rivaroxaban—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00021	0.000902	CcSEcCtD
Rivaroxaban—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00021	0.000902	CcSEcCtD
Rivaroxaban—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00021	0.000899	CcSEcCtD
Rivaroxaban—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000209	0.000895	CcSEcCtD
Rivaroxaban—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000209	0.000894	CcSEcCtD
Rivaroxaban—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000208	0.000894	CcSEcCtD
Rivaroxaban—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000208	0.000893	CcSEcCtD
Rivaroxaban—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000208	0.000893	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000208	0.000892	CcSEcCtD
Rivaroxaban—Rash—Stavudine—acquired immunodeficiency syndrome	0.000208	0.000892	CcSEcCtD
Rivaroxaban—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000208	0.000891	CcSEcCtD
Rivaroxaban—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000208	0.000891	CcSEcCtD
Rivaroxaban—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000208	0.00089	CcSEcCtD
Rivaroxaban—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000207	0.000889	CcSEcCtD
Rivaroxaban—Headache—Stavudine—acquired immunodeficiency syndrome	0.000207	0.000886	CcSEcCtD
Rivaroxaban—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000207	0.000886	CcSEcCtD
Rivaroxaban—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000206	0.000884	CcSEcCtD
Rivaroxaban—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000206	0.000884	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000206	0.000883	CcSEcCtD
Rivaroxaban—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000206	0.000882	CcSEcCtD
Rivaroxaban—Rash—Abacavir—acquired immunodeficiency syndrome	0.000205	0.000878	CcSEcCtD
Rivaroxaban—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000205	0.000878	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000205	0.000877	CcSEcCtD
Rivaroxaban—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000205	0.000877	CcSEcCtD
Rivaroxaban—Headache—Abacavir—acquired immunodeficiency syndrome	0.000204	0.000873	CcSEcCtD
Rivaroxaban—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000203	0.000872	CcSEcCtD
Rivaroxaban—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000203	0.00087	CcSEcCtD
Rivaroxaban—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000203	0.00087	CcSEcCtD
Rivaroxaban—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000201	0.000863	CcSEcCtD
Rivaroxaban—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000201	0.00086	CcSEcCtD
Rivaroxaban—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.0002	0.000859	CcSEcCtD
Rivaroxaban—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.0002	0.000858	CcSEcCtD
Rivaroxaban—ABCB1—brain—acquired immunodeficiency syndrome	0.000199	0.00569	CbGeAlD
Rivaroxaban—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000199	0.000854	CcSEcCtD
Rivaroxaban—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000199	0.000852	CcSEcCtD
Rivaroxaban—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000199	0.000852	CcSEcCtD
Rivaroxaban—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000199	0.000852	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000197	0.000845	CcSEcCtD
Rivaroxaban—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000196	0.000843	CcSEcCtD
Rivaroxaban—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000196	0.000842	CcSEcCtD
Rivaroxaban—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000196	0.000841	CcSEcCtD
Rivaroxaban—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000196	0.000841	CcSEcCtD
Rivaroxaban—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000196	0.00084	CcSEcCtD
Rivaroxaban—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000193	0.000827	CcSEcCtD
Rivaroxaban—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000192	0.0055	CbGeAlD
Rivaroxaban—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000192	0.000825	CcSEcCtD
Rivaroxaban—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000192	0.000824	CcSEcCtD
Rivaroxaban—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000191	0.000821	CcSEcCtD
Rivaroxaban—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000191	0.00082	CcSEcCtD
Rivaroxaban—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000191	0.00082	CcSEcCtD
Rivaroxaban—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000191	0.00082	CcSEcCtD
Rivaroxaban—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000191	0.000817	CcSEcCtD
Rivaroxaban—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000191	0.000817	CcSEcCtD
Rivaroxaban—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.00019	0.000817	CcSEcCtD
Rivaroxaban—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00019	0.000813	CcSEcCtD
Rivaroxaban—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000189	0.00081	CcSEcCtD
Rivaroxaban—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000189	0.000809	CcSEcCtD
Rivaroxaban—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000186	0.000796	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000185	0.000794	CcSEcCtD
Rivaroxaban—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000185	0.000793	CcSEcCtD
Rivaroxaban—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000184	0.000787	CcSEcCtD
Rivaroxaban—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000183	0.000787	CcSEcCtD
Rivaroxaban—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000183	0.000787	CcSEcCtD
Rivaroxaban—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.000782	CcSEcCtD
Rivaroxaban—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000182	0.000782	CcSEcCtD
Rivaroxaban—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000182	0.000781	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000182	0.000781	CcSEcCtD
Rivaroxaban—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000181	0.000775	CcSEcCtD
Rivaroxaban—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000181	0.000775	CcSEcCtD
Rivaroxaban—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000181	0.000774	CcSEcCtD
Rivaroxaban—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.00018	0.000772	CcSEcCtD
Rivaroxaban—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00018	0.00077	CcSEcCtD
Rivaroxaban—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000178	0.000764	CcSEcCtD
Rivaroxaban—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000178	0.000761	CcSEcCtD
Rivaroxaban—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000177	0.000759	CcSEcCtD
Rivaroxaban—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000177	0.000758	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000177	0.000758	CcSEcCtD
Rivaroxaban—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000176	0.000756	CcSEcCtD
Rivaroxaban—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000176	0.000756	CcSEcCtD
Rivaroxaban—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000176	0.000755	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000175	0.000752	CcSEcCtD
Rivaroxaban—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000175	0.00075	CcSEcCtD
Rivaroxaban—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000175	0.00075	CcSEcCtD
Rivaroxaban—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000173	0.000741	CcSEcCtD
Rivaroxaban—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000172	0.000739	CcSEcCtD
Rivaroxaban—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00017	0.000731	CcSEcCtD
Rivaroxaban—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.00017	0.000731	CcSEcCtD
Rivaroxaban—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00017	0.00073	CcSEcCtD
Rivaroxaban—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.00017	0.000727	CcSEcCtD
Rivaroxaban—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000169	0.000727	CcSEcCtD
Rivaroxaban—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000169	0.000723	CcSEcCtD
Rivaroxaban—Rash—Indinavir—acquired immunodeficiency syndrome	0.000168	0.000721	CcSEcCtD
Rivaroxaban—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000168	0.00072	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.000717	CcSEcCtD
Rivaroxaban—Headache—Indinavir—acquired immunodeficiency syndrome	0.000167	0.000716	CcSEcCtD
Rivaroxaban—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000167	0.000714	CcSEcCtD
Rivaroxaban—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000165	0.000707	CcSEcCtD
Rivaroxaban—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000164	0.000704	CcSEcCtD
Rivaroxaban—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.000697	CcSEcCtD
Rivaroxaban—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.000694	CcSEcCtD
Rivaroxaban—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00016	0.000687	CcSEcCtD
Rivaroxaban—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.00016	0.000686	CcSEcCtD
Rivaroxaban—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000159	0.000683	CcSEcCtD
Rivaroxaban—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000159	0.000681	CcSEcCtD
Rivaroxaban—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000159	0.00068	CcSEcCtD
Rivaroxaban—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000158	0.000679	CcSEcCtD
Rivaroxaban—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000158	0.000678	CcSEcCtD
Rivaroxaban—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000158	0.000677	CcSEcCtD
Rivaroxaban—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000158	0.000676	CcSEcCtD
Rivaroxaban—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000154	0.00066	CcSEcCtD
Rivaroxaban—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000153	0.000657	CcSEcCtD
Rivaroxaban—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000152	0.000654	CcSEcCtD
Rivaroxaban—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000152	0.000652	CcSEcCtD
Rivaroxaban—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000152	0.000651	CcSEcCtD
Rivaroxaban—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.000651	CcSEcCtD
Rivaroxaban—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000151	0.000647	CcSEcCtD
Rivaroxaban—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000151	0.000646	CcSEcCtD
Rivaroxaban—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00015	0.000642	CcSEcCtD
Rivaroxaban—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000147	0.000632	CcSEcCtD
Rivaroxaban—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000147	0.00063	CcSEcCtD
Rivaroxaban—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.000629	CcSEcCtD
Rivaroxaban—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.000621	CcSEcCtD
Rivaroxaban—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000143	0.000614	CcSEcCtD
Rivaroxaban—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.000608	CcSEcCtD
Rivaroxaban—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000608	CcSEcCtD
Rivaroxaban—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00014	0.000603	CcSEcCtD
Rivaroxaban—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00014	0.000602	CcSEcCtD
Rivaroxaban—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.0006	CcSEcCtD
Rivaroxaban—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00014	0.000599	CcSEcCtD
Rivaroxaban—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000585	CcSEcCtD
Rivaroxaban—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.00058	CcSEcCtD
Rivaroxaban—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000135	0.00058	CcSEcCtD
Rivaroxaban—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000135	0.000579	CcSEcCtD
Rivaroxaban—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000134	0.000576	CcSEcCtD
Rivaroxaban—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.000568	CcSEcCtD
Rivaroxaban—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000558	CcSEcCtD
Rivaroxaban—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.000553	CcSEcCtD
Rivaroxaban—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.000553	CcSEcCtD
Rivaroxaban—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000128	0.00055	CcSEcCtD
Rivaroxaban—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.000546	CcSEcCtD
Rivaroxaban—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000521	CcSEcCtD
